Ward6 has launched a new campaign for world leading diabetes care company, Novo Nordisk. The objective is to inspire the medical community to consider individual needs of patients when it comes to prescribing medicines. 

Novo Nordisk Senior Product Manager, Kylie Myers, said, “The management of Type 1 diabetes is much more serious than regular Type 2 diabetes. Patients often need up to four insulin injections a day as well as regular blood glucose tests. Ward 6’s innovation has truly captured the medical arena’s attention.”

Ward6 Creative Director, Hugh Fitzhardinge, said, “Novo Nordisk have always been at the forefront of diabetes care. In fact, the company developed the original insulin.  As well as this campaign Ward6 have partnered with Novo Nordisk to develop specialised medical content and an educational platform for specialists, GPs and nurses.”